-
Product Insights
Bladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Bladder cancer occurs in tissues of the urinary bladder whose symptoms include blood or blood clots in the urine, frequent urination, lower back pain on one side of the body, and burning during urination. Risk factors for bladder cancer include smoking, exposure to substances such as rubber, certain dyes and textiles, paint, and hairdressing supplies, diet rich in fried meats and fat, old age, sex and color, and certain parasitic infections. The Bladder Cancer pipeline market research report provides comprehensive...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – nadofaragene firadenovec
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry nadofaragene firadenovec Drug Details Nadofaragene firadenovec (Instiladrin, SCH-721015) is under development for the treatment...
-
Report Bundle
26% offTrends in Pharma – Report Bundle (4 Reports)
‘The pharmaceutical sector is witnessing a massive revamp. It has been conventionally slow in the adoption of technology and is now undergoing rapid changes due to the development of several technologies as well as innovations. From modern cancer research facilities to gene treatment centers, the novel association between the human mind and technology has become a self-evolving matter. Post-COVID, equipped with cutting-edge technology, the prominent pharma industry tends to invest increasingly in inter-organizational collaborations to boost a favorable environment for...
-
Sector Analysis
Gene Therapy Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Oncology Therapy Type (Oncolytic Virotherapy, Gene Transfer, Gene Induced Immunotherapy) and End-user (Hospitals, Diagnostic Centers, Research Institutes), 2022–2027
The gene therapy in oncology market size was valued at US$ 2,045 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 23.7% during 2022-2027. The key to the growth has been the high prevalence of cancer and growing demand for gene therapy over conventional therapies. Additionally, key strategic partnerships and mergers and acquisitions are expected to accelerate market growth. Over the forecast period, the market will witness an  increase in government support for...
-
Product Insights
Malignant Mesothelioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Malignant Mesothelioma pipeline market report provides a comprehensive overview of the therapeutics under development for Malignant Mesothelioma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Malignant Mesothelioma and features...
-
Product Insights
Syringes, Needles and Urinary Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
A syringe is a tube-like device used to intake and expel liquid. A needle is a very thin piece of tubular metal with a hollow interior. Needles are generally fitted with a plastic connector. A urinary catheter is a thin piece of flexible tubing that is used to collect urine from a patient into a drainage bag. GlobalData's Medical Devices sector report, “Syringes, Needles and Urinary Catheters - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Syringes,...
-
Thematic Analysis
Gene Therapy in Oncology – Thematic Research
Gene therapy is the introduction of exogenous, genetic material into cells to treat a disease. Gene therapies provide therapeutic benefits to patients, especially those suffering from monogenic diseases. Cancers are generally not monogenic in origin, so gene therapies are more likely to be used to treat cancer by modifying gene regulation in tumorigenic pathways and expressing genes in cells that cause them to be recognized as foreign, or to elicit an immune response to tumorigenic cells. Sales of products that...
-
Sector Analysis
Bladder Cancer – Dynamic Market Forecast to 2025
Bladder cancer is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the bladder cancer space, including regulatory, commercial, and clinical events as well as understand how all of these events will impact the projected market forecast.
-
Sector Analysis
OpportunityAnalyzer: Bladder Cancer – Opportunity Analysis and Forecasts to 2025
The bladder cancer market in the seven major pharmaceutical markets (US, France, Germany, Italy, Spain, UK, and Japan) has remained largely unchanged in the past 10-20 years. However, significant expansion is expected starting in 2016, with the introduction of several new therapies that are projected to fuel market growth. In addition, bladder cancer has a robust early-stage pipeline that will contribute to market growth during the forecast period. Currently, the bladder cancer market is dominated by generic chemotherapy and immunotherapy....
-
Track & Monitor
Gene Therapy Market Opportunity For CMOs – 2019 PharmSource Edition
This report will explore whether the bio/pharma industry is adequately prepared for future gene therapy developments and whether CDMOs are making appropriate investments in the capacity and technology to support the coming opportunity.